"Oscar is on track to return to profitability this year. We expect a significant year-over-year improvement of nearly $750 million in earnings from operations in 2026, representing the midpoint of our guidance. Oscar's 2026 guidance targets earnings from operations of $250 million to $450 million, against a 2025 loss from operations of $396 million."
"Our Agentic AI bot for care guides reduced response times by 67% during peak open enrollment periods. Oswell, our industry-first health agent, now completes 86% of questions received from members with high accuracy and quality. That's not a pilot program. That's operational infrastructure."
Oscar Health reported disappointing Q4 2025 results with an EPS miss and medical loss ratio of 95.4%, yet the stock rose 9.6% on CEO Mark Bertolini's 2026 profitability promise. The company projects a dramatic $750 million improvement in operating earnings for 2026, targeting $250-450 million against a 2025 operating loss of $396 million. This turnaround depends on reducing the medical loss ratio to 82.4-83.4%. Bertolini is executing three strategies: deploying AI-driven efficiency tools including an Agentic AI bot reducing response times by 67% and a health agent completing 86% of member questions, implementing pricing discipline with a 28% weighted average rate increase, and capitalizing on the expiration of enhanced premium subsidies.
#healthcare-insurance #artificial-intelligence #financial-guidance #medical-loss-ratio #profitability-strategy
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]